1. A compound of the formula
(Z)x
wherein:
each Z is independently selected from a 2′-deoxythymidinyl moiety, a 2′-deoxyuridinyl moiety, a 2′-deoxyadenosinyl moiety, a 2′-deoxyinosinyl moiety, a 2′-deoxycytidinyl moiety, a 5-methyl-2′-deoxycytidinyl moiety, a 7-deaza 2′-deoxyguanosinyl moiety, or a corresponding 2′-O-methyl ribonucleosidyl counterpart of the 2′-deoxythymidinyl moiety, the 2′-deoxyuridinyl moiety, the 2′-deoxyadenosinyl moiety, the 2′-deoxyinosinyl moiety, the 2′-deoxycytidinyl moiety, the 5-methyl-2′-deoxycytidinyl moiety, or the 7-deaza 2′-deoxyguanosinyl moiety,
x is an integer from 5-20,
said Z moieties are connected by thiophosphate triester linkages, wherein
3-12 of said thiophosphate triester linkages being positively charged linkages of the formula:
wherein n is an integer from 2 to 6, and
the remainder of said thiophosphate triester linkages are neutral linkages of the formula:
wherein each R1 is C4-C10 alkyl;
provided that when x is 5-6, the number of positively charged linkages is 3, when x is 7-8, the number of positively charged linkages is 3-4, when x is 9-12, the number of positively charged linkages is 3-10, when x is 13-20, the number of positively charged linkages is 4-12.
2. The compound of claim 1, wherein n is an integer from 2 to 6.
3. The compound of claim 1, having the formula (dT)x, (dU)x, (dA)x, (dI)x, (dC)x, d(5-MeC)x, d(7-deazaG)x, (2′-O-methyl U)x, (2′-O-methyl A)x, (2′-O-methyl C)x, (2′-O-methyl 5-MeC)x, (2′-O-me